Nick Muscato's most recent trade in Amedisys Inc. was a trade of 32,620 Common Stock done . Disclosure was reported to the exchange on Aug. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 32,620 | 0 (0%) | 0% | - | Common Stock | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 3,468 | 3,468 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 3,468 | 0 (0%) | 0% | - | Common Stock | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 3,468 | 0 | - | - | Restricted Stock Unit (Performance-Based Vesting) | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 3,067 | 32,620 (0%) | 0% | - | Common Stock | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 2,876 | 0 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 2,040 | 0 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 708 | 0 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 563 | 0 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 320 | 0 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 272 | 0 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 212 | 0 (0%) | 0% | - | Common Stock | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.94 per share. | 25 Jul 2025 | 31 | 35,687 (0%) | 0% | 97.9 | 3,036 | Common Stock |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.09 per share. | 20 Feb 2025 | 292 | 35,718 (0%) | 0% | 91.1 | 26,598 | Common Stock |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 5,832 | 36,661 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.60 per share. | 16 Feb 2025 | 651 | 36,010 (0%) | 0% | 92.6 | 60,283 | Common Stock |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 10,421 | 30,829 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.75 per share. | 25 Jul 2024 | 108 | 20,408 (0%) | 0% | 97.8 | 10,557 | Common Stock |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 5,518 | 20,843 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.69 per share. | 16 Feb 2024 | 327 | 20,516 (0%) | 0% | 93.7 | 30,637 | Common Stock |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.02 per share. | 25 Jul 2023 | 170 | 15,325 (0%) | 0% | 91.0 | 15,473 | Common Stock |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,876 | 2,876 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,725 | 2,725 | - | - | Restricted Stock Unit (Performance-Based Vesting) | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 1,363 | 15,495 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.16 per share. | 20 Feb 2023 | 106 | 14,132 (0%) | 0% | 97.2 | 10,299 | Common Stock |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2022 | 11,555 | 14,238 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Nick Muscato | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.18 per share. | 25 Jul 2022 | 719 | 2,683 (0%) | 0% | 128.2 | 92,161 | Common Stock |